Quarterly report pursuant to Section 13 or 15(d)

Consolidated Condensed Statements of Cash Flows

v3.24.2.u1
Consolidated Condensed Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jun. 29, 2024
Jul. 01, 2023
Cash Flows from Operating Activities:    
Net Loss $ (1,645) $ (16,414)
Adjustments to Reconcile Net Loss to Cash Flows from Operating Activities:    
Depreciation and Amortization 12,531 13,373
Amortization of Deferred Financing Fees 1,695 1,363
Provisions for Non-Cash Losses on Inventory and Receivables 2,415 1,705
Equity-based Compensation Expense 4,642 3,992
Operating Lease Non-Cash Expense 2,562 2,563
Non-Cash 401K Contribution and Quarterly Bonus Accrual 3,454 2,536
Non-Cash Annual Stock Bonus Accrual 1,448 0
Net Gain on Sale of Business, Before Taxes 0 (3,427)
Non-Cash Deferred Liability Recovery 0 (5,824)
Other 1,827 (1,275)
Changes in Operating Assets and Liabilities Providing (Using) Cash:    
Accounts Receivable (15,281) (22,619)
Inventories (11,398) (22,638)
Accounts Payable (4,661) 14,081
Accrued Expenses 9,255 5,611
Customer Advance Payments and Deferred Revenue (4,280) 959
Income Taxes (4,487) 7,422
Operating Lease Liabilities (2,447) (2,674)
Supplemental Retirement Plan Liabilities (209) (206)
Other Assets and Liabilities 356 321
Net Cash from Operating Activities (4,223) (21,151)
Cash Flows from Investing Activities:    
Proceeds from Sale of Business and Assets 0 3,427
Capital Expenditures (3,394) (3,806)
Net Cash from Investing Activities (3,394) (379)
Cash Flows from Financing Activities:    
Proceeds from Long-term Debt 15,392 131,732
Principal Payments on Long-term Debt (9,498) (112,774)
Stock Award Activity (3,172) (601)
Financing-related Costs (1,837) (6,388)
Finance Lease Principal Payments (70) (24)
Other (10) 0
Net Cash from Financing Activities 805 11,945
Effect of Exchange Rates on Cash (109) 101
Decrease in Cash and Cash Equivalents and Restricted Cash (6,921) (9,484)
Cash and Cash Equivalents and Restricted Cash at Beginning of Period 11,313 13,778
Cash and Cash Equivalents and Restricted Cash at End of Period $ 4,392 $ 4,294